- Home
- Publications
- Publication Search
- Publication Details
Title
Current state of Alzheimer’s fluid biomarkers
Authors
Keywords
Alzheimer’s disease, Amyloid, Biomarker, Blood, Cerebrospinal fluid, Tau
Journal
ACTA NEUROPATHOLOGICA
Volume 136, Issue 6, Pages 821-853
Publisher
Springer Nature
Online
2018-11-28
DOI
10.1007/s00401-018-1932-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
- (2018) Courtney L. Sutphen et al. Alzheimers & Dementia
- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
- (2018) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage
- (2018) Brianne M. Bettcher et al. JOURNAL OF ALZHEIMERS DISEASE
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
- (2018) Ilijana Begcevic et al. Journal of Proteomics
- Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis
- (2018) Siddharth Nath et al. LANCET
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Sex differences in Alzheimer disease — the gateway to precision medicine
- (2018) Maria Teresa Ferretti et al. Nature Reviews Neurology
- Precision pharmacology for Alzheimer’s disease
- (2018) Harald Hampel et al. PHARMACOLOGICAL RESEARCH
- Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease
- (2018) Frederic Brosseron et al. Alzheimers Research & Therapy
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease
- (2018) Michael Ewers et al. JOURNAL OF ALZHEIMERS DISEASE
- Human Platelets Tau: A Potential Peripheral Marker for Alzheimer's Disease
- (2018) Karen Neumann et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased Protein-Conjugated Acrolein and Amyloid-β40/42 Ratio in Plasma of Patients with Mild Cognitive Impairment and Alzheimer's Disease
- (2018) Masaaki Waragai et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes
- (2018) Armand Perret-Liaudet et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ1-40 Improves Differential Dementia Diagnosis in Patients with Intermediate P-tau181P Levels
- (2018) Sylvie Slaets et al. JOURNAL OF ALZHEIMERS DISEASE
- α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
- (2018) Ane Korff et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
- (2018) Nan Hu et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease
- (2018) Barbara Mroczko et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
- (2018) Anna Antonell et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
- (2017) Filippo Baldacci et al. Expert Review of Proteomics
- Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
- (2017) Christelle Gervaise-Henry et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
- (2017) Maarten Timmers et al. JOURNAL OF ALZHEIMERS DISEASE
- Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
- (2017) Yi Jayne Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
- (2017) Simone Lista et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer’s Disease
- (2017) Stephanie M. Williams et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease
- (2017) Kacie D. Deters et al. JOURNAL OF ALZHEIMERS DISEASE
- A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer’s Disease
- (2017) Rui Guo et al. JOURNAL OF ALZHEIMERS DISEASE
- Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease
- (2017) Antero Salminen et al. JOURNAL OF NEUROCHEMISTRY
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
- (2017) Marta Querol-Vilaseca et al. Journal of Neuroinflammation
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies
- (2017) Ka Sing P Lai et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evidence that iron accelerates Alzheimer’s pathology: a CSF biomarker study
- (2017) Scott Ayton et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study
- (2017) Johan Ljungqvist et al. JOURNAL OF NEUROTRAUMA
- Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1–42 in CSF for the Diagnosis of Alzheimer’s Disease
- (2017) Gwënaël Pottiez et al. JOURNAL OF PROTEOME RESEARCH
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
- (2017) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
- (2017) Franc Llorens et al. MOLECULAR NEUROBIOLOGY
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- TREM2 in Neurodegenerative Diseases
- (2017) Taylor R. Jay et al. Molecular Neurodegeneration
- Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
- (2017) K Goozee et al. MOLECULAR PSYCHIATRY
- Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
- (2017) Manuel Delgado-Alvarado et al. MOVEMENT DISORDERS
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
- (2017) Rebecca Sims et al. NATURE GENETICS
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- Putting AD treatments and biomarkers to the test
- (2017) Eric M. Reiman Nature Reviews Neurology
- Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
- (2017) Joana B. Pereira et al. NEUROBIOLOGY OF AGING
- Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
- (2017) Simone Lista et al. NEUROCHEMISTRY INTERNATIONAL
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
- (2017) Daniel Alcolea et al. NEUROLOGY
- Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
- (2017) Pashtun Shahim et al. NEUROLOGY
- Plasma neurofilament light chain levels in Alzheimer’s disease
- (2017) Wenjun Zhou et al. NEUROSCIENCE LETTERS
- Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study
- (2017) Luisa Agnello et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation
- (2017) Qiu-Shuang Zhang et al. TOXICOLOGY LETTERS
- The blood brain barrier in Alzheimer’s disease
- (2017) A. Chakraborty et al. VASCULAR PHARMACOLOGY
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Neurofilaments and Neurofilament Proteins in Health and Disease
- (2017) Aidong Yuan et al. Cold Spring Harbor Perspectives in Biology
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
- (2017) Nour K. Majbour et al. Scientific Reports
- Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
- (2017) Kira S. Sheinerman et al. Alzheimers Research & Therapy
- Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
- (2017) Jong-Chan Park et al. Alzheimers Research & Therapy
- Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
- (2017) Min Jeong Wang et al. Alzheimers Research & Therapy
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
- (2017) Davide Chiasserini et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
- (2017) Camilla Lauridsen et al. Frontiers in Aging Neuroscience
- Association of Cerebrospinal Fluid Ferritin Level With Preclinical Cognitive Decline in APOE-ε4 Carriers
- (2017) Scott Ayton et al. JAMA Neurology
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
- (2017) Michelle M. Mielke et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
- (2017) Riqiang Yan Frontiers in Molecular Neuroscience
- The Multifaceted Role of SNARE Proteins in Membrane Fusion
- (2017) Jing Han et al. Frontiers in Physiology
- Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
- (2017) Rose Ann Huynh et al. Frontiers in Neurology
- Pharmacodynamic effects of daclizumab in the intrathecal compartment
- (2017) Mika Komori et al. Annals of Clinical and Translational Neurology
- Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
- (2017) Nobuto Kakuda et al. Acta Neuropathologica Communications
- Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design
- (2017) Ineke A. van Rossum et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology
- (2017) Sandra D. Mulder et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies
- (2016) Carlo Ballatore et al. ACS Chemical Neuroscience
- Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids
- (2016) Mathew H. Horrocks et al. ACS Chemical Neuroscience
- CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
- (2016) Ju-Hee Kang et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort
- (2016) Jeffrey L. Dage et al. Alzheimers & Dementia
- Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
- (2016) Juan Domingo Gispert et al. Alzheimers & Dementia
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Genomic variants, genes, and pathways of Alzheimer's disease: An overview
- (2016) Adam C. Naj et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
- (2016) Guro Berge et al. BMC Neurology
- Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
- (2016) Raphael Hesse et al. BMC Neurology
- TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
- (2016) Bryan D. James et al. BRAIN
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Physiological and pathological roles of the γ-secretase complex
- (2016) Courtney M. Carroll et al. BRAIN RESEARCH BULLETIN
- Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
- (2016) Lidia Bakota et al. DRUGS
- Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- (2016) Niklas Mattsson et al. EMBO Molecular Medicine
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
- (2016) J. Mellergård et al. EUROPEAN JOURNAL OF NEUROLOGY
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease
- (2016) Edward J. Goetzl et al. FASEB JOURNAL
- The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease
- (2016) Ann De Vos et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
- (2016) Stephen P. Arnerić et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer’s Disease
- (2016) Andrea Slachevsky et al. JOURNAL OF ALZHEIMERS DISEASE
- Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment
- (2016) Mirjana Babić Leko et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors
- (2016) Amado Rivero-Santana et al. JOURNAL OF ALZHEIMERS DISEASE
- Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
- (2016) Claire L. Russell et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study
- (2016) H. Bea Kuiperij et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid
- (2016) Judith Schuster et al. JOURNAL OF ALZHEIMERS DISEASE
- Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges
- (2016) Dana Kim et al. Journal of Clinical Neurology
- Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer’s disease and in mild cognitive impairment due to AD
- (2016) Cristina Sanfilippo et al. JOURNAL OF NEURAL TRANSMISSION
- Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
- (2016) Lenka Novakova et al. JOURNAL OF NEUROCHEMISTRY
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology
- (2016) Trevor Tyson et al. JOURNAL OF NEUROCHEMISTRY
- Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies
- (2016) A W Lemstra et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
- (2016) Lenka Novakova et al. Multiple Sclerosis Journal
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
- (2016) Keun-A Chang et al. NEUROCHEMISTRY INTERNATIONAL
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
- (2016) Joana S. Cristóvão et al. Oxidative Medicine and Cellular Longevity
- Tauopathies as clinicopathological entities
- (2016) David J. Irwin PARKINSONISM & RELATED DISORDERS
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Imaging synaptic density in the living human brain
- (2016) Sjoerd J. Finnema et al. Science Translational Medicine
- Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
- (2016) Niklas Mattsson et al. Nature Communications
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
- (2016) Panagiotis Alexopoulos et al. Alzheimers Research & Therapy
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
- (2016) Malin Degerman Gunnarsson et al. Alzheimers Research & Therapy
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Biomarker-guided classification scheme of neurodegenerative diseases
- (2016) Filippo Baldacci et al. Journal of Sport and Health Science
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
- (2016) Lenka Novakova et al. Multiple Sclerosis Journal
- Tau: The Center of a Signaling Nexus in Alzheimer's Disease
- (2016) Shahzad S. Khan et al. Frontiers in Neuroscience
- Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
- (2016) Martin Ingelsson Frontiers in Neuroscience
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
- (2016) Urmi Sengupta et al. EBioMedicine
- Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease
- (2016) Giorgio Vivacqua et al. PLoS One
- Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
- (2016) Shashank Shekhar et al. PLoS One
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
- (2016) J. M. G. van Bergen et al. Scientific Reports
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia
- (2015) Panos Roussos et al. Alzheimers & Dementia
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
- (2015) Michael Ewers et al. Alzheimers & Dementia
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
- (2015) Heather M. Snyder et al. Alzheimers & Dementia
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability
- (2015) Anthony Fourier et al. CLINICA CHIMICA ACTA
- Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease
- (2015) D. Inekci et al. Current Alzheimer Research
- YKL-40/CHI3L1 drives inflammation on the road of tumor progression
- (2015) Stephania Libreros et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Microglia and neuroprotection
- (2015) Zhihong Chen et al. JOURNAL OF NEUROCHEMISTRY
- The Role of TDP-43 in Alzheimer’s Disease
- (2015) Xiao-Long Chang et al. MOLECULAR NEUROBIOLOGY
- Spreading of pathology in neurodegenerative diseases: a focus on human studies
- (2015) Johannes Brettschneider et al. NATURE REVIEWS NEUROSCIENCE
- A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
- (2015) Frances K. Wiseman et al. NATURE REVIEWS NEUROSCIENCE
- Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
- (2015) Daniel Alcolea et al. NEUROBIOLOGY OF AGING
- Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles
- (2015) Luigi Yuri Di Marco et al. NEUROBIOLOGY OF DISEASE
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
- (2015) Xuling Li et al. Neurotherapeutics
- The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
- (2015) Malin Wennström et al. PLoS One
- TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer’s Disease and Schizophrenia
- (2015) Yoko Mori et al. PLoS One
- Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
- (2015) Scott Ayton et al. Nature Communications
- Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
- (2015) Hlin Kvartsberg et al. Alzheimers Research & Therapy
- Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
- (2015) Maartje I. Kester et al. Alzheimers Research & Therapy
- A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid
- (2015) Ting Yang et al. Alzheimers Research & Therapy
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease
- (2015) Rawan Tarawneh et al. JAMA Neurology
- Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
- (2015) Luca Steardo et al. Frontiers in Neuroscience
- Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
- (2015) Maria João Leitão et al. Frontiers in Neurology
- Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
- (2015) Aaron Ritter et al. Frontiers in Neurology
- Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
- (2015) Aline Dorey et al. Frontiers in Neurology
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies
- (2015) Joery Goossens et al. Acta Neuropathologica Communications
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
- (2014) Thomas A. Bayer et al. ACTA NEUROPATHOLOGICA
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
- (2014) Christopher C. Rowe et al. ANNALS OF NEUROLOGY
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
- (2014) Robert Vassar et al. JOURNAL OF NEUROCHEMISTRY
- Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
- (2014) Takashi Kasai et al. JOURNAL OF NEUROLOGY
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies
- (2014) Pradip K. Kamat et al. MOLECULAR NEUROBIOLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
- (2014) Shichun Tu et al. Molecular Neurodegeneration
- Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
- (2014) Jing L Guo et al. NATURE MEDICINE
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
- (2014) Josef Pannee et al. NEUROSCIENCE LETTERS
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study
- (2014) Thomas Leyhe et al. Alzheimers Research & Therapy
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Alpha-synuclein biology in Lewy body diseases
- (2014) Woojin Scott Kim et al. Alzheimers Research & Therapy
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis
- (2014) Daniel Ferreira et al. Frontiers in Aging Neuroscience
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease
- (2014) Tobias Skillbäck et al. JAMA Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
- (2013) Simone Lista et al. Alzheimers & Dementia
- Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
- (2013) Robert Perneczky et al. Alzheimers & Dementia
- Criteria for mild cognitive impairment due to alzheimer's disease in the community
- (2013) Ronald C. Petersen et al. ANNALS OF NEUROLOGY
- Amylin deposition in the brain: A second amyloid in Alzheimer disease?
- (2013) Kaleena Jackson et al. ANNALS OF NEUROLOGY
- Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities
- (2013) Neena Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
- (2013) Harald Hampel et al. BIOCHEMICAL PHARMACOLOGY
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
- (2013) Jon B. Toledo et al. BRAIN
- Identification of an important potential confound in CSF AD studies: aliquot volume
- (2013) Jamie Toombs et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The Diagnostic Value of CSF Amyloid-β43 in Differentiation of Dementia Syndromes
- (2013) Kim Bruggink et al. Current Alzheimer Research
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions
- (2013) Fredrik Olsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies
- (2013) Xinni Luo et al. JOURNAL OF NEUROCHEMISTRY
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dual Cleavage of Neuregulin 1 Type III by BACE1 and ADAM17 Liberates Its EGF-Like Domain and Allows Paracrine Signaling
- (2013) D. Fleck et al. JOURNAL OF NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
- (2013) Rahul S Desikan et al. Molecular Neurodegeneration
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
- (2013) Carlos Cruchaga et al. NEURON
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
- (2013) Mikko Hölttä et al. PLoS One
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
- (2013) Jere E. Meredith Jr. et al. PLoS One
- The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease
- (2013) Elisabeth Kapaki et al. PLoS One
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- A delicate balance: Iron metabolism and diseases of the brain
- (2013) Dominic Hare et al. Frontiers in Aging Neuroscience
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
- (2013) Ju-Hee Kang JAMA Neurology
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
- (2012) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- Neurofilaments at a glance
- (2012) A. Yuan et al. JOURNAL OF CELL SCIENCE
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
- (2012) Guoxin Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood and plasma-based proteomic biomarker research in Alzheimer's disease
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- Biological and methodical challenges of blood-based proteomics in the field of neurological research
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Examining the mechanisms that link β-amyloid and α-synuclein pathologies
- (2012) Samuel E Marsh et al. Alzheimers Research & Therapy
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- Role of amyloid β1–42 and neuroimaging biomarkers in Alzheimer’s disease
- (2011) Simone Lista et al. Biomarkers in Medicine
- CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
- (2011) Mingli Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials
- (2011) Maria Isaac et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease
- (2011) Jihye Choi et al. JOURNAL OF NEUROLOGY
- Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
- (2011) Niklas Mattsson et al. NEUROMOLECULAR MEDICINE
- Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
- (2010) William T. Hu et al. ACTA NEUROPATHOLOGICA
- Abnormal Neurites Containing C-Terminally Truncated α-Synuclein Are Present in Alzheimer's Disease without Conventional Lewy Body Pathology
- (2010) Karen A. Lewis et al. AMERICAN JOURNAL OF PATHOLOGY
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
- (2010) Inna Kuperstein et al. EMBO JOURNAL
- Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease
- (2010) Adam P. Gunn et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Neurogranin, a link between calcium/calmodulin and protein kinase C signaling in synaptic plasticity
- (2010) F. Javier Díez-Guerra IUBMB LIFE
- CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies
- (2010) E. Mulugeta et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- TAR DNA-binding protein 43 in neurodegenerative disease
- (2010) Alice S. Chen-Plotkin et al. Nature Reviews Neurology
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
- (2010) Min Shi et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
- (2009) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment
- (2009) K. Blennow et al. Journal of Nutrition Health & Aging
- A novel pathway for amyloid precursor protein processing
- (2009) Erik Portelius et al. NEUROBIOLOGY OF AGING
- Relationships between biomarkers in aging and dementia
- (2009) W. J. Jagust et al. NEUROLOGY
- Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
- (2009) Peder Buchhave et al. PLoS One
- TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration
- (2008) Penelope Foulds et al. ACTA NEUROPATHOLOGICA
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
- (2008) Michael Ewers et al. BRAIN
- Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects
- (2008) Guoxin Wu et al. CLINICAL BIOCHEMISTRY
- The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients
- (2008) J.-M. Lee et al. CLINICAL CHEMISTRY
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
- (2008) K. A. Josephs et al. NEUROLOGY
- Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease
- (2007) Harald Hampel et al. Alzheimers & Dementia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now